INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1788431592-patent-application-desk-glasses-pen-paper]( "The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly")
The Patent Cliff Looms – Design Your Biosimilar Approach AccordinglyIn your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
![GettyImages-171223483-cell-culture-microscope-assay]( "Easy Automation For Cell-Based Assays")
Easy Automation For Cell-Based AssaysAutomated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
-
![Straight from the source]( "Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™")
Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.
-
![Early Material Generation Whitepaper_header image]( "Advancing Cell Culture Strategies To Accelerate Biologics Development")
Advancing Cell Culture Strategies To Accelerate Biologics DevelopmentIntegrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Tips And Tricks Addressing PCR Pain Points3/5/2026
qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.
-
How Isogenic Organ-Chips Are Transforming The Future Of Research6/25/2026
Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.
-
Advancing Cell Therapies With Lipid Nanoparticles3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations8/27/2025
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
Enabling Flexibility And Scientific Innovation In OSD Development8/31/2026
How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.
DRUG DEVELOPMENT SOLUTIONS
-
![FLIPR Penta High-Throughput Cellular Screening System]( "FLIPR Penta High-Throughput Cellular Screening System")
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.
-
![GettyImages-512051390-antibody-antibodies]( "Alzheimer's Imaging, Simplified")
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.
-
![GettyImages-155374807-molecule-molecular]( "Small Molecules Discovery")
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
![Networking, Pharmaceutical logistician-GettyImages-997784670]( "Morpho: Alfasigma Contract Development & Manufacturing")
A CDMO built inside a pharmaceutical group pairs sterile injectables, oral solids, and carnitine API chemistry with early-stage development, while keeping client IP behind internal firewalls.
-
![cellular protein synthesis. mRNA vaccine research-GettyImages-2249044433]( "Secure Scalable Supply Of Critical Assay Proteins For Diagnostic R&D")
Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:
